Cost-Effectiveness of Initiating Pharmacological Treatment in Stage One Hypertension Based on 10-Year Cardiovascular Disease Risk: A Markov Modeling Study

Antihypertensive drug treatment is cost-effective for adults at high risk of developing cardiovascular disease (CVD). However, the cost-effectiveness in people with stage 1 hypertension (140–159 mm Hg systolic blood pressure) at lower CVD risk remains unclear. The objective was to establish the 10-y...

Descripción completa

Detalles Bibliográficos
Autores principales: Constanti, Margaret, Floyd, Christopher N., Glover, Mark, Boffa, Rebecca, Wierzbicki, Anthony S., McManus, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803450/
https://www.ncbi.nlm.nih.gov/pubmed/33342242
http://dx.doi.org/10.1161/HYPERTENSIONAHA.120.14913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803450/
https://www.ncbi.nlm.nih.gov/pubmed/33342242
http://dx.doi.org/10.1161/HYPERTENSIONAHA.120.14913

Ejemplares similares